1. Home
  2. ONVO vs MGRX Comparison

ONVO vs MGRX Comparison

Compare ONVO & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONVO
  • MGRX
  • Stock Information
  • Founded
  • ONVO 2007
  • MGRX 2021
  • Country
  • ONVO United States
  • MGRX United States
  • Employees
  • ONVO N/A
  • MGRX N/A
  • Industry
  • ONVO Biotechnology: Biological Products (No Diagnostic Substances)
  • MGRX Computer Software: Prepackaged Software
  • Sector
  • ONVO Health Care
  • MGRX Technology
  • Exchange
  • ONVO Nasdaq
  • MGRX Nasdaq
  • Market Cap
  • ONVO 6.5M
  • MGRX 6.3M
  • IPO Year
  • ONVO N/A
  • MGRX 2023
  • Fundamental
  • Price
  • ONVO $0.39
  • MGRX $2.61
  • Analyst Decision
  • ONVO
  • MGRX
  • Analyst Count
  • ONVO 0
  • MGRX 0
  • Target Price
  • ONVO N/A
  • MGRX N/A
  • AVG Volume (30 Days)
  • ONVO 243.5K
  • MGRX 96.9K
  • Earning Date
  • ONVO 02-06-2025
  • MGRX 11-14-2024
  • Dividend Yield
  • ONVO N/A
  • MGRX N/A
  • EPS Growth
  • ONVO N/A
  • MGRX N/A
  • EPS
  • ONVO N/A
  • MGRX N/A
  • Revenue
  • ONVO $103,000.00
  • MGRX $755,000.00
  • Revenue This Year
  • ONVO $59.08
  • MGRX N/A
  • Revenue Next Year
  • ONVO $18.24
  • MGRX N/A
  • P/E Ratio
  • ONVO N/A
  • MGRX N/A
  • Revenue Growth
  • ONVO N/A
  • MGRX 52.20
  • 52 Week Low
  • ONVO $0.32
  • MGRX $2.07
  • 52 Week High
  • ONVO $1.74
  • MGRX $16.80
  • Technical
  • Relative Strength Index (RSI)
  • ONVO 47.81
  • MGRX 52.13
  • Support Level
  • ONVO $0.34
  • MGRX $2.07
  • Resistance Level
  • ONVO $0.51
  • MGRX $2.77
  • Average True Range (ATR)
  • ONVO 0.06
  • MGRX 0.17
  • MACD
  • ONVO -0.00
  • MGRX 0.01
  • Stochastic Oscillator
  • ONVO 30.00
  • MGRX 77.70

About ONVO Organovo Holdings Inc.

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Share on Social Networks: